Cytosorbents (CTSO) Competitors $1.00 +0.11 (+11.96%) Closing price 04:00 PM EasternExtended Trading$0.99 -0.01 (-0.90%) As of 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTSO vs. BWAY, SMTI, CVRX, SKIN, MGRM, CV, SGHT, INGN, PROF, and KRMDShould you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Brainsway (BWAY), Sanara MedTech (SMTI), CVRx (CVRX), Beauty Health (SKIN), Monogram Orthopaedics (MGRM), CapsoVision (CV), Sight Sciences (SGHT), Inogen (INGN), Profound Medical (PROF), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry. Cytosorbents vs. Its Competitors Brainsway Sanara MedTech CVRx Beauty Health Monogram Orthopaedics CapsoVision Sight Sciences Inogen Profound Medical KORU Medical Systems Brainsway (NASDAQ:BWAY) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends. Do insiders & institutionals believe in BWAY or CTSO? 30.1% of Brainsway shares are owned by institutional investors. Comparatively, 32.9% of Cytosorbents shares are owned by institutional investors. 19.0% of Brainsway shares are owned by insiders. Comparatively, 7.3% of Cytosorbents shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility & risk, BWAY or CTSO? Brainsway has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Does the media favor BWAY or CTSO? In the previous week, Cytosorbents had 6 more articles in the media than Brainsway. MarketBeat recorded 6 mentions for Cytosorbents and 0 mentions for Brainsway. Cytosorbents' average media sentiment score of 0.60 beat Brainsway's score of 0.00 indicating that Cytosorbents is being referred to more favorably in the news media. Company Overall Sentiment Brainsway Neutral Cytosorbents Positive Is BWAY or CTSO more profitable? Brainsway has a net margin of 9.01% compared to Cytosorbents' net margin of -41.77%. Brainsway's return on equity of 7.35% beat Cytosorbents' return on equity.Company Net Margins Return on Equity Return on Assets Brainsway9.01% 7.35% 4.72% Cytosorbents -41.77%-105.04%-29.18% Which has preferable earnings and valuation, BWAY or CTSO? Brainsway has higher revenue and earnings than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsway$41.02M5.42$2.92M$0.2058.80Cytosorbents$35.33M1.77-$20.72M-$0.28-3.57 Do analysts recommend BWAY or CTSO? Brainsway presently has a consensus target price of $14.25, indicating a potential upside of 21.17%. Cytosorbents has a consensus target price of $5.50, indicating a potential upside of 450.00%. Given Cytosorbents' higher possible upside, analysts clearly believe Cytosorbents is more favorable than Brainsway.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainsway 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Cytosorbents 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryBrainsway beats Cytosorbents on 12 of the 16 factors compared between the two stocks. Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTSO vs. The Competition Export to ExcelMetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.61M$10.37B$5.45B$9.68BDividend YieldN/A2.02%3.99%4.14%P/E Ratio-3.5719.6130.1125.01Price / Sales1.7721.67379.5578.79Price / CashN/A21.8135.9458.58Price / Book5.002.898.135.68Net Income-$20.72M$211.77M$3.26B$265.68M7 Day Performance15.05%3.59%1.15%2.51%1 Month Performance-4.76%4.33%2.81%1.88%1 Year Performance-3.85%-9.79%28.41%24.00% Cytosorbents Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTSOCytosorbents1.7419 of 5 stars$1.00+12.0%$5.50+450.0%-18.1%$62.61M$35.33M-3.57220News CoverageEarnings ReportAnalyst ForecastGap UpBWAYBrainsway2.5177 of 5 stars$11.72+2.2%$14.25+21.6%+73.5%$216.75M$41.02M58.60120SMTISanara MedTech1.5917 of 5 stars$24.76+2.5%$49.50+99.9%-10.0%$214.73M$86.67M-18.4860Upcoming EarningsCVRXCVRx2.9208 of 5 stars$7.55-0.1%$14.50+92.1%-18.4%$197.11M$51.29M-3.46160News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionSKINBeauty Health0.4924 of 5 stars$1.60+4.6%$2.08+30.2%+27.2%$192.77M$334.30M-3.901,030Earnings ReportGap UpMGRMMonogram Orthopaedics1.7002 of 5 stars$5.47+1.5%$5.40-1.3%+139.6%$192.36M$370K-12.1628Upcoming EarningsCVCapsoVisionN/A$4.10+4.9%$5.50+34.1%N/A$181.21MN/A0.0090Quiet Period ExpirationSGHTSight Sciences1.8806 of 5 stars$3.47+6.1%$3.93+13.4%-35.6%$169.04M$79.87M-3.54210News CoverageEarnings ReportAnalyst UpgradeGap UpINGNInogen4.2143 of 5 stars$6.54+5.3%$11.00+68.2%-47.0%$166.97M$335.70M-5.691,030News CoverageEarnings ReportGap UpPROFProfound Medical1.8107 of 5 stars$5.64+2.5%$11.00+95.2%-40.9%$165.29M$10.68M-4.62150News CoverageKRMDKORU Medical Systems1.9063 of 5 stars$3.38-2.9%$4.63+36.8%+81.7%$160.57M$33.65M-30.7380News CoverageEarnings Report Related Companies and Tools Related Companies BWAY Competitors SMTI Competitors CVRX Competitors SKIN Competitors MGRM Competitors CV Competitors SGHT Competitors INGN Competitors PROF Competitors KRMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTSO) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTSO Stock Alerts